MedTrace Logo

Rapid Atrial Pacing After TAVI to Predict Pacemaker Implantation

NCT06189976 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2024-12-12

No results posted yet for this study

Summary

Despite Transcatheter aortic valve implantation (TAVI) evolution regarding techniques, equipment and experience, the need for permanent pacemaker implantation (PPI) post-TAVI remains an important drawback. The electrophysiology testing to stratify the risk or necessity of PPI post-TAVI is endorsed by the up-to-date guidelines and consensus documents and it is a valuable cut-off based method. Part of the answer is maybe hidden in the easy and applicable testing of the atrioventricular conduction system through rapid atrial pacing (RAP) with a common temporary pacemaker lead. This trial is designed to investigate the role and value of RAP after TAVI as a predictor of the necessity of new PPI.

Conditions

  • Aortic Valve Disease
  • Transcatheter Aortic Valve Implantation
  • TAVI

Interventions

DIAGNOSTIC_TEST

Rapid atrial pacing

Rapid atrial pacing after TAVI

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Saint Pierre

    collaborator OTHER

  • National and Kapodistrian University of Athens

    lead OTHER

Principal Investigators

  • Leonidas Koliastasis · National and Kapodistrian University of Athens

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2025-04-30
Completion
2025-12-31

Countries

  • Belgium
  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06189976 on ClinicalTrials.gov